Particle.news
Download on the App Store

France Confirms Moderate Covid Resurgence as XFG Variant Dominates

Health surveillance shows higher consultations across services without evidence of greater severity.

Overview

  • Santé publique France reports 2,628 Covid-related medical acts for Sept. 22–28, a 15.7% weekly increase.
  • Emergency data show suspected Covid visits among people aged 75 and over up 24% (+30 visits), with volumes comparable to last year.
  • SOS Médecins notes Covid incidence among patients with acute respiratory infections remained stable week to week at a moderate level.
  • XFG, a recombinant Omicron lineage under WHO monitoring, now predominates in Europe and the United States.
  • France’s targeted autumn–winter vaccination for older and vulnerable people starts 14 October and runs through January 2026, as the ECDC notes rising circulation with limited hospital impact so far.